Avid Bioservices Inc (CDMO)
7.64
+0.08
(+1.06%)
USD |
NASDAQ |
Apr 30, 16:00
7.625
-0.02
(-0.20%)
Pre-Market: 20:00
Avid Bioservices Cash from Investing (Quarterly): -4.488M for Jan. 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -4.488M |
| October 31, 2023 | -7.468M |
| July 31, 2023 | -14.16M |
| April 30, 2023 | -25.06M |
| January 31, 2023 | -11.30M |
| October 31, 2022 | -34.41M |
| July 31, 2022 | -6.869M |
| April 30, 2022 | -24.57M |
| January 31, 2022 | -20.02M |
| October 31, 2021 | -7.625M |
| July 31, 2021 | -4.199M |
| April 30, 2021 | -4.147M |
| January 31, 2021 | -2.737M |
| October 31, 2020 | -2.491M |
| July 31, 2020 | -0.489M |
| April 30, 2020 | -0.787M |
| January 31, 2020 | -2.04M |
| October 31, 2019 | -0.947M |
| July 31, 2019 | -0.038M |
| April 30, 2019 | -0.208M |
| January 31, 2019 | -0.802M |
| October 31, 2018 | 2.746M |
| July 31, 2018 | 2.808M |
| April 30, 2018 | 1.351M |
| January 31, 2018 | -0.335M |
| Date | Value |
|---|---|
| October 31, 2017 | -1.406M |
| July 31, 2017 | -0.403M |
| April 30, 2017 | -0.62M |
| January 31, 2017 | -1.373M |
| October 31, 2016 | -0.691M |
| July 31, 2016 | -0.375M |
| April 30, 2016 | -1.308M |
| January 31, 2016 | -3.408M |
| October 31, 2015 | -3.371M |
| July 31, 2015 | -0.704M |
| April 30, 2015 | -4.783M |
| January 31, 2015 | -2.136M |
| October 31, 2014 | -0.697M |
| July 31, 2014 | -0.833M |
| April 30, 2014 | -0.757M |
| January 31, 2014 | -0.672M |
| October 31, 2013 | -0.843M |
| July 31, 2013 | -0.25M |
| April 30, 2013 | -0.01M |
| January 31, 2013 | -0.231M |
| October 31, 2012 | -0.145M |
| July 31, 2012 | -0.365M |
| April 30, 2012 | -0.102M |
| January 31, 2012 | -0.192M |
| October 31, 2011 | -0.545M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-34.41M
Minimum
Oct 2022
-0.038M
Maximum
Jul 2019
-9.149M
Average
-4.488M
Median
Jan 2024
Cash from Investing (Quarterly) Benchmarks
| Emergent BioSolutions Inc | -11.40M |
| Creative Medical Technology Holdings Inc | 1.126M |
| Viking Therapeutics Inc | -459.79M |
| Stereotaxis Inc | 0.00 |
| MAIA Biotechnology Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.687M |
| Cash from Financing (Quarterly) | 0.085M |
| Free Cash Flow | -38.50M |
| Free Cash Flow Per Share (Quarterly) | -0.0127 |
| Free Cash Flow to Equity (Quarterly) | -1.068M |
| Free Cash Flow to Firm (Quarterly) | -0.0564M |
| Free Cash Flow Yield | -7.95% |